Schimke Immunoosseous DysplasiaQ87.1

Last updated on: 03.07.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

HistoryThis section has been translated automatically.

Schimke RN et al (1974).

DefinitionThis section has been translated automatically.

Schimke immunoosseous dysplasia is a rare disorder characterized by the combination of spondyloepiphyseal dysplasia (SED) with a distinctive clinical phenotype, numerous lentigines, a slowly progressive immunodeficiency, and immune complex nephritis. It leads to death at about 8 years of age. Like ADA deficiency (102700), cartilage-hair hypoplasia (250250), and Shwachman syndrome (260400), this disorder combines abnormalities of the immune and skeletal systems. Affected individuals suffer from T-cell deficiency.

Less common signs and symptoms of Schimke immunodysplasia include early-onset atherosclerosis, cerebral ischemia, migraine-like headaches, hypothyroidism, and lymphopenia. Further inconstant is a hypoplastic pelvis, microcephaly, and azoospermia.

EtiopathogenesisThis section has been translated automatically.

"Schimke immunoosseous dysplasia" (SIOD) is caused by a homozygous or compound heterozygous mutation in the SMARCAL1 gene (606622) on chromosome 2q25.

Note(s)This section has been translated automatically.

Schimke's immunoosseous dysplasia was first described by Schimke et al. (1974) as "chondroitin-6-sulfate mucopolysaccharidosis." Later studies failed to confirm mucopolysacchariduria and excluded mucopolysaccharidosis (Spranger et al. 1991).

LiteratureThis section has been translated automatically.

  1. Baradaran-Heravi A et al (2008) Clinical and genetic distinction of Schimke immuno-osseous dysplasia and cartilage-hair hypoplasia. Am J Med Genet 146A: 2013-2017.
  2. Boerkoel CF et al (2000) Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Europ J Pediat 159: 1-7.
  3. Clewing JM et al (2007) Schimke immuno-osseous dysplasia: a clinicopathological correlation. J Med Genet 44: 122-130.
  4. Ehrich JHH et al (1990) Association of spondylo-epiphyseal dysplasia with nephrotic syndrome. Pediat Nephrol 4: 117-121.
  5. Hashimoto K et al (1994) Juvenile variant of Schimke immunoosseous dysplasia. Am J Med Genet 49: 266-269.
  6. Schimke RN et al (1974) Chondroitin-6-sulfate mucopolysaccharidosis in conjunction with lymphopenia, defective cellular immunity and the nephrotic syndrome. Birth Defects Orig Art Ser X(12): 258-266.
  7. Spranger J et al (1991) Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. J Pediat 119: 64-72.

Last updated on: 03.07.2022